MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0007342
Udi Pharma Private Limited
Udi Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.15 Cr
▲ 2% YoY
Net profit · FY 2025
₹8.18 Lakh
Net margin 3.8%
EBITDA · FY 2025
₹11.13 Lakh
EBITDA margin 5.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Udi Pharma Private Limited
Data last updated:
Udi Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC356877. Its GSTIN is 07AACCU5108J1ZC (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arunoday Singh and Kiran Magotra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 90 B 2nd / F Block Ba Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.15 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹8.18 Lakh (net margin 3.8%) and EBITDA of ₹11.13 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
Udi Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0007342).
Company Details of Udi Pharma Private Limited
CIN U24230DL2019PTC356877
Registration Number 356877
Incorporation Date 30 October 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0007342
Key People
Arunoday Singh Director Kiran Magotra Director Recognitions & Rankings of Udi Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No 90 B 2nd / F Block Ba Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Udi Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Udi Pharma Private Limited
The main business activity of Udi Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Udi Pharma Private Limited FY 2025 filings available
Udi Pharma Private Limited reported revenue of ₹2.15 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹2.15 Cr ▲ 2%
Net profit · FY 2025
₹8.18 Lakh margin 3.8%
EBITDA · FY 2025
₹11.13 Lakh margin 5.2%
Compounded Annual Growth Rate (CAGR) of Udi Pharma Private Limited
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 55%
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 2% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Udi Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Udi Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Udi Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Udi Pharma Private Limited
Udi Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arunoday Singh | Director | 30 Oct 2019 | 6 Years 11 Months | Current |
| Kiran Magotra Also directs: Green Wellness LLP, Sai Sparsh Management and Engineering Private Limited, Suntech Industries Private Limited and 5 more | Director | 30 Oct 2019 | 6 Years 11 Months | Current |
Peer Comparison of Udi Pharma Private Limited
Udi Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Crambola Fashions Private Limited | ₹2.16 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Gurugram, Haryana, India |
| Netro Enterprises (OPC) Private Limited | ₹2.16 Cr (FY 2023) | •••• | •••• | -47.0% | •••• | Hyderabad, Telangana, India |
| Kingbrain Solution Private Limited | ₹2.16 Cr (FY 2024) | •••• | •••• | 124.0% | •••• | Dibrugarh, Assam, India |
| Abhivrudhi Vet India Private Limited | ₹2.16 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Hyderabad, Telangana, India |
| Deepali Saree Museum Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Udi Pharma Private Limited this company | ₹2.15 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Unatgagan Commodities Pvt Ltd | ₹2.15 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Dadri, Uttar Pradesh, India |
| Itochu Worldwide Technology Private Limited | ₹2.15 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Chennai, Tamil Nadu, India |
| Maishvi Chikankari Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | 408.0% | •••• | Lajpat Nagar, Uttar Pradesh, India |
| Hiralal Ventures Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | 142.0% | •••• | Islampur, Bihar, India |
| Bittu Bizicon Private Limited | ₹2.15 Cr (FY 2024) | •••• | •••• | 3238.0% | •••• | Raxaul, Bihar, India |
Peers are the five companies nearest above and the five nearest below Udi Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Udi Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Udi Pharma Private Limited
Udi Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Udi Pharma Private Limited
Employment history and EPFO contributions of people linked to Udi Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Udi Pharma Private Limited
Udi Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Arunoday Singh was appointed as Director on 30 Oct 2019.
AGM
Udi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Udi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Arunoday Singh was appointed as Director.
Appointed
Kiran Magotra was appointed as Director.
Incorporation
30 Oct 2019
Udi Pharma Private Limited was registered on 30 Oct 2019 with Roc Delhi I & aged 6 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Udi Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Udi Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Udi Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Udi Pharma Private Limited
Udi Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCU5108J1ZC | Delhi | Active | 14 Nov 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Udi Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Udi Pharma Private Limited
Udi Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 October 2019 (7+ years old) and is registered under CIN U24230DL2019PTC356877.
Udi Pharma reported revenue of ₹2.15 Cr for FY 2025 (up 2% YoY).
Udi Pharma has 2 current directors:
- Arunoday Singh - Director
- Kiran Magotra - Director
Udi Pharma reported a net profit of ₹8.18 Lakh (net margin 3.8%) and EBITDA of ₹11.13 Lakh (EBITDA margin 5.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Udi Pharma is 19% over three years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Udi Pharma is 07AACCU5108J1ZC, registered in Delhi.
The CIN (Corporate Identification Number) of Udi Pharma is U24230DL2019PTC356877. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Udi Pharma was incorporated on 30 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Udi Pharma by revenue are Crambola Fashions Private Limited, Netro Enterprises (OPC) Private Limited, Kingbrain Solution Private Limited, Abhivrudhi Vet India Private Limited, Deepali Saree Museum Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Arunoday Singh was appointed as Director on 30 Oct 2019. Kiran Magotra was appointed as Director on 30 Oct 2019.
Yes, Udi Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0007342).